<- Go Home
LTT Bio-Pharma Co.,Ltd.
LTT Bio-Pharma Co., Ltd. engages in the research and development of drugs and technologies, etc. primarily in Japan. Its products include prostaglandin E1 formulations for intravenous injections; nonsteroidal anti-inflammatory formulations for intravenous injections; transdermal steroid formulations; and halopredone acetate formulations, as well as lipo-PGE1, a drug delivery system. The company also develops a therapeutic agent, which is in Phase II clinical trial for treating dry eyes. LTT Bio-Pharma Co., Ltd. was founded in 1988 and is based in Tokyo, Japan.
Market Cap
N/A
Volume
3.6K
Cash and Equivalents
N/A
EBITDA
-JPY 445.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
JPY 61.0M
Profit Margin
100.00%
52 Week High
N/A
52 Week Low
N/A
Dividend
N/A
Price / Book Value
N/A
Price / Earnings
N/A
Price / Tangible Book Value
N/A
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-JPY 446.0M
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
N/A
Debt
N/A
Equity
N/A
Revenue
JPY 61.0M
Unlevered FCF
N/A
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium